{"nct_id":"NCT05132127","title":"Sutimlimab (BIVV009) for the Adult Participants With Cold Agglutinin Disease (CAD) Who Have Completed Phase 3 Studies (CARDINAL or CADENZA) in Japan","status":"COMPLETED","status_verified_date":"2025-09","start_date":"2021-11-11","start_date_type":"ACTUAL","primary_completion_date":"2022-11-15","primary_completion_date_type":"ACTUAL","completion_date":"2022-11-15","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["SNY"]}